INVO Fertility (IVF) Cash from Financing Activities (2011 - 2026)

INVO Fertility (IVF) has 15 years of Cash from Financing Activities data on file, last reported at $5.0 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 35.36% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 86.29% increase from a year earlier, with the FY2024 full-year figure at $3.1 million, down 57.8% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $5.0 million, up from $1.6 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for IVF reached as high as $5.0 million in Q1 2026 and fell as low as -$169856.0 in Q2 2023.
• Historically, Cash from Financing Activities has averaged $1.5 million across 5 years, with a median of $800000.0 in 2022.
• On a YoY basis, Cash from Financing Activities climbed as much as 17753.12% in 2023 and fell as far as 117.69% in 2023.
• Year by year, Cash from Financing Activities stood at $800000.0 in 2022, then slumped by 117.69% to -$141527.0 in 2023, then surged by 449.09% to $494050.0 in 2024, then surged by 222.09% to $1.6 million in 2025, then soared by 211.27% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $5.0 million in Q1 2026, $1.6 million in Q3 2025, and $1.4 million in Q2 2025.